Stemcell Holdings, Inc. Stock Other OTC
Equities
STMM
US85858N2027
Pharmaceuticals
Financials (USD)
Sales 2016 | 3.34M | Sales 2017 | 6.18M | Capitalization | 1.64M |
---|---|---|---|---|---|
Net income 2016 | 1M | Net income 2017 | 2M | EV / Sales 2016 * | - |
Net cash position 2016 * | - | Net cash position 2017 * | - | EV / Sales 2017 * | - |
P/E ratio 2016 * |
-
| P/E ratio 2017 * |
-
| Employees | - |
Yield 2016 * |
-
| Yield 2017 * |
-
| Free-Float | 0.95% |
1st Jan change | Capi. | |
---|---|---|
+1.45% | 40.51B | |
-15.94% | 31.67B | |
+52.66% | 24.62B | |
-14.50% | 15.65B | |
-14.38% | 12.07B | |
-9.12% | 11.97B | |
-42.56% | 11.61B | |
+4.87% | 8.81B | |
-4.33% | 8.5B |